[ TRANSACTION RECORD ]

Hellman & Friedman Investment in Cordis — 2023

VERIFIED VECTOR ID: 001523 · tx-051
M SOURCE NODE — FUNDER
Finance United States
$2,200,000,000
EQUITY
12/01/2023
Q DESTINATION NODE — RECIPIENT
Company United States
Amount (USD)
$2.2B
Flow Type
EQUITY
Transaction Date
12/01/2023
Primary Source
Funder Profile [ M ]
AUM 90000
HQ Location United States
Sector Finance
Recipient Profile [ Q ]
Entity Cordis
Entity Type Company
Jurisdiction United States
Intelligence Note

Hellman & Friedman completed the 2.2 billion dollar acquisition of Cordis from Cardinal Health to drive growth in interventional vascular technology. The transaction focuses on revitalizing the brand’s product pipeline and expanding its international market share. This deal is a classic example of private equity driving value in a healthcare carve-out.